Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.

Detalles Bibliográficos
Publicado en:European Journal of Nuclear Medicine & Molecular Imaging Vol. 29; no. 9; pp. 1118 - 1119
Autores principales: Reinhardt, Michael J., Brink, Ingo, Joe, Alexius Y., von Mallek, Dirk, Ezziddin, Samer, Palmedo, Holger, Krause, Thomas M.
Formato: Journal Article
Publicado: Springer Nature 2002
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104324260&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104324260
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        16197070
        NPC
      jtl: European Journal of Nuclear Medicine & Molecular Imaging
      issn: 16197070
      maglogo: N
    pubinfo:
      dt: 2002
      vid: 29
      iid: 9
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104324260
        2011945509
        104324260
      ppf: 1118
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
      aug:
        au:
          Reinhardt, Michael J.
          Brink, Ingo
          Joe, Alexius Y.
          von Mallek, Dirk
          Ezziddin, Samer
          Palmedo, Holger
          Krause, Thomas M.
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N